214 results on '"Von Bergwelt-Baildon, Michael S."'
Search Results
2. Data from Post-transplant Malignancies Show Reduced T-cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance
3. Supplementary Figure from Post-transplant Malignancies Show Reduced T-cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance
4. Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis
5. Cytokine release syndrome
6. Post-transplant Malignancies Show Reduced T-cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance
7. T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option
8. Post-transplant Malignancies Show Reduced T-cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance
9. T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option
10. Chimeric Antigen Receptor T Cells in Myeloma
11. The role of B cells in the pathogenesis of graft-versus-host disease
12. Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?
13. The cyclins: a family of widely expressed tumor antigens?
14. Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma
15. Cyclins against cancer: a novel family of tumor antigens?
16. The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells
17. Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1
18. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy
19. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies
20. Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma
21. Autoantibodies frequently detected in patients with aplastic anemia
22. The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
23. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies
24. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application
25. Nail dystrophy due to dose-intensive chemotherapy
26. Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
27. Critical care of patients with cancer.
28. Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
29. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells
30. Critical Care of Patients With Cancer
31. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
32. Tumor-Infiltrating B Lymphocytes Characterized by CD79a and MUM1 Independently Predict Outcome in Patients with Non-Small Cell Lung Cancer
33. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome‐dependent cytosolic pathway in CD40‐activated B cells
34. Characterization of tumor-associated B cell subsets in head and neck squamous cell carcinoma.
35. Comprehensive characterization of PDL-1 and CTLA-4 in gastric cancer.
36. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
37. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
38. p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance
39. Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity
40. Flamsa Reduced-Intensity Conditioning Regimen in AML Patients - Role of Re-Induction and Disease State Prior to Transplant
41. The CD21(low) B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset
42. p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance
43. Flamsa Reduced-Intensity Conditioning Regimen in AML Patients – Role of Re-Induction and Disease State Prior to Transplant
44. The CD21low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset
45. Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity
46. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
47. Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution
48. The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect
49. Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells
50. Primed for Death: Hypoxia Sensitizes Primary CLL Cells towards Compounds Targeting Mitochondrial Integrity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.